Report cover image

Global Syndromic Multiplex Diagnostics Market Size Study, by Type (Respiratory, Gastrointestinal, Central Nervous System), by End Use (Hospitals, Diagnostic Laboratories, Others), and Regional Forecasts 2024-2034

Publisher Factview Research
Published Oct 03, 2025
Length 285 Pages
SKU # FAVR20464239

Description

The Global Syndromic Multiplex Diagnostics Market was valued at approximately USD 2.92 billion in 2024 and is anticipated to grow at a CAGR of 4.1% over the forecast period 2025-2034. The increasing demand for rapid and accurate diagnostics, advancements in molecular diagnostic technologies, and the rising prevalence of infectious diseases are among the key factors driving market growth. The widespread occurrence of diseases such as respiratory infections, gastrointestinal diseases, and sexually transmitted infections (STIs) has fueled the demand for syndromic testing. According to the World Health Organization (WHO), in 2024, tuberculosis (TB) caused 1.25 million deaths, with an estimated 10.8 million people developing TB, affecting men, women, and children worldwide. This increasing burden of infectious diseases is significantly boosting the demand for effective diagnostic solutions, driving the growth of the syndromic multiplex diagnostics market.

Advancements in molecular diagnostics have played a crucial role in market expansion. Technologies such as next-generation sequencing (NGS) and advanced polymerase chain reaction (PCR) assays have significantly improved the sensitivity and specificity of syndromic multiplex diagnostics. For example, in September 2024, Roche launched the Cobas Respiratory Flex test, a novel syndromic multiplex PCR assay that can identify up to 15 respiratory pathogens from a single patient sample. This test enhances diagnostic efficiency, provides rapid results, and eliminates the need for multiple tests, ultimately streamlining laboratory workflows and improving patient care.

Moreover, increased investments in research and development (R&D) by market players are further fueling innovation. In September 2024, Seegene partnered with Springer Nature to offer research grants aimed at advancing syndromic PCR diagnostic assays. This initiative focuses on enhancing innovation in molecular diagnostics, encouraging new methodologies and the development of assays for emerging pathogens and mutations. The growing emphasis on diagnostic capabilities for infectious diseases highlights the importance of syndromic multiplex diagnostics in public health advancements.

From a geographical perspective, North America holds the largest market share due to the high prevalence of infectious diseases, strong presence of key market players, and stringent regulatory standards ensuring the adoption of effective diagnostic solutions. Europe is also a significant market, driven by technological advancements and an aging population that is highly susceptible to infections. Meanwhile, Asia-Pacific is expected to witness the fastest growth, particularly in China, India, and Japan, due to developing healthcare infrastructure and growing investments in diagnostic technologies.

Major Market Players Included in This Report Are:
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • F. Hoffmann-La Roche Ltd
  • Qiagen
  • bioMérieux
  • DiaSorin S.p.A (Luminex Corporation)
  • Hologic, Inc.
  • Becton, Dickinson and Company (BD)
  • Applied BioCode
  • QIAGEN
  • Curetis GmbH
  • QuidelOrtho Corporation
  • Cepheid
  • Randox Laboratories
  • Seegene
The Detailed Segments and Sub-Segments of the Market Are Explained Below:

By Type
  • Respiratory
  • Gastrointestinal
  • Central Nervous System
  • Other Types of Syndromes (cUTI and STDs)
By End Use
  • Hospitals
  • Diagnostic Laboratories
  • Others
By Region:

North America
  • U.S.
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Sweden
  • Denmark
  • Norway
Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
Latin America
  • Brazil
  • Argentina
Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Kuwait
Years Considered for the Study Are As Follows:
  • Historical Year: 2022
  • Base Year: 2024
  • Forecast Period: 2024 to 2034
Key Takeaways:
  • Market Estimates & Forecast for 10 Years (2022-2034)
  • Annualized Revenue and Regional Analysis for Each Market Segment
  • Geographical Landscape with Country-Level Analysis for Major Regions
  • Competitive Landscape with Key Market Players
  • Analysis of Key Business Strategies and Recommendations for Market Approach
  • Demand-Side and Supply-Side Market Analysis

Table of Contents

285 Pages
Chapter 1. Global Syndromic Multiplex Diagnostics Market Executive Summary
1.1. Global Syndromic Multiplex Diagnostics Market Size & Forecast (2024-2034)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Industry Metrics
1.7. Investment Analysis
1.8 .Investment Rationale
1.9. Analyst Recommendation & Conclusion
Chapter 2. Global Syndromic Multiplex Diagnostics Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Syndromic Multiplex Diagnostics Market Dynamics
3.1. Market Drivers
3.1.1. Rising prevalence of infectious diseases
3.1.2. Advancements in molecular diagnostics technologies
3.1.3. Increasing demand for rapid and accurate diagnostic solutions
3.2. Market Challenges
3.2.1. High costs associated with syndromic diagnostic assays
3.2.2. Stringent regulatory requirements delaying approvals
3.3. Market Opportunities
3.3.1. Expansion of diagnostic capabilities in emerging economies
3.3.2. Rising investments in research and development
Chapter 4. Global Syndromic Multiplex Diagnostics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Top Winning Strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Syndromic Multiplex Diagnostics Market Size & Forecasts by Type 2022-2032
5.1. Segment Dashboard
5.2. Global Syndromic Multiplex Diagnostics Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Respiratory
5.2.2. Gastrointestinal
5.2.3. Central Nervous System
5.2.4. Other Types of Syndromes (cUTI and STDs)
Chapter 6. Global Syndromic Multiplex Diagnostics Market Size & Forecasts by End-Use 2022-2032
6.1. Segment Dashboard
6.2. Global Syndromic Multiplex Diagnostics Market: End-Use Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Hospitals
6.2.2. Diagnostic Laboratories
6.2.3. Others
Chapter 7. Global Syndromic Multiplex Diagnostics Market Size & Forecasts by Region 2022-2032
7.1. North America
7.1.1. U.S.
7.1.2. Canada
7.1.3. Mexico
7.2. Europe
7.2.1. U.K.
7.2.2. Germany
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Sweden
7.2.7. Denmark
7.2.8. Norway
7.3. Asia-Pacific
7.3.1. Japan
7.3.2. China
7.3.3. India
7.3.4. Australia
7.3.5. South Korea
7.3.6. Thailand
7.4. Latin America
7.4.1. Brazil
7.4.2. Argentina
7.5. Middle East & Africa
7.5.1. Saudi Arabia
7.5.2. South Africa
7.5.3. UAE
7.5.4. Kuwait
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Abbott Laboratories
8.1.2. Thermo Fisher Scientific, Inc.
8.1.3. F. Hoffmann-La Roche Ltd
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Abbott Laboratories
8.3.2. Thermo Fisher Scientific, Inc.
8.3.3. F. Hoffmann-La Roche Ltd
8.3.4. Qiagen
8.3.5. bioMérieux
8.3.6. DiaSorin S.p.A (Luminex Corporation)
8.3.7. Hologic, Inc.
8.3.8. Becton, Dickinson and Company (BD)
8.3.9. Applied BioCode
8.3.10. Seegene
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us